"Non-Triangle Plane" Surgical Technique of Video-Assisted Thoracic Surgery Atypical Segmentectomy for Stage IA Non-Small-Cell Lung Cancer: Early Experience

胸腔镜辅助非典型肺段切除术治疗IA期非小细胞肺癌:早期经验——“非三角平面”手术技术

阅读:1

Abstract

Objectives: To evaluate the safety and feasibility of a novel surgical technique ("non-triangle plane" technique) of two-port (mini-utility) video-assisted thoracic surgery (VATS) atypical segmentectomy (S(3)+S(1+2)c) with tunneling stapler for small-sized non-small-cell lung cancers (NSCLCs) located in left S(3) close to the intersegmental plane between S(3) and S(1+2)c. Materials and Methods: This retrospective descriptive study included 16 patients who, between April 2016 and December 2019, underwent a single two-port (mini-utility) VATS atypical segmentectomy (S(3)+S(1+2)c) with tunneling stapler technique for small-sized NSCLCs with a ground-glass opacity (GGO) rate of more than 50% by a constant surgical team in two hospitals. Perioperative data and survival data were collected and retrospectively analyzed. Postoperative follow-up was performed every 6 months. Results: Six patients were with adenocarcinoma in situ, and ten were with minimally invasive adenocarcinoma. The mean surgical margin was 14.06 ± 3.02 mm. The mean operation time was 53.88 ± 9.76 min. The mean duration of chest tube drainage was 4 ± 1.21 days, and the median length of postoperative hospital stay was 4 days. There was no perioperative morbidity and mortality. The median follow-up was 47.5 months (17-61 months). No recurrences occurred, and all patients were still alive at the last registered follow-up (May 31, 2021). Conclusion: Two-port (mini-utility) VATS atypical segmentectomy (S(3)+S(1+2)c) with tunneling stapler technique is a safe and feasible option for the treatment of small-sized NSCLCs located in left S(3) close to the intersegmental plane between S(3) and S(1+2)c.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。